NMPA Approval

Recombinant Human Interferon α2a for Injection

Approval Number

国药准字S10960043

Registration Date

August 31, 2020

Previous Approval Numbers

国药准字S10960043

Drug Information

Generic Name

注射用重组人干扰素α2a

Dosage Form

冻干粉针剂

Strength

300万IU

Drug Type

生物制品

Registration Date

August 31, 2020

Company Address

长春市高新技术开发区创新路1616号

Company Address

长春市高新技术开发区创新路1616号

Empowering clinical research with data-driven insights and AI-powered tools.

注射用重组人干扰素α2a - NMPA 批准文号 | MedPath